Skip to main content

Table 3 Standardised incidence ratios (SIR) for invasive cancers in the D2C cohort

From: Cancer incidence in type 2 diabetes patients - first results from a feasibility study of the D2C cohort

Cancer type (ICD-10)

SIR

 

Men

99% CI

Women

99% CI

All

99% CI

Any cancer (excluding C 44*)

1.11

[1.01-1.21]

1.18

[1.07-1.31]

1.14

[1.04-1.21]

Liver (C 22)

1.88

[1.02-3.15]

2.08

[0.78-4.46]

1.94

[1.18-2.99]

Pancreas (C 25)

1.27

[0.68-2.15]

1.63

[0.93-2.63]

1.45

[0.97-2-06]

Breast (C 50)

-

-

0.86

[0.68-1.07]

-

-

Prostate (C 61)

0.65

[0.52-0.82]

-

-

-

-

Colorectal (C18 - C21)

1.00

[0.77-1.23]

0,97

[0.73-1.28]

0.99

[0.81-1.19]

Lung (C34)

1.04

[0.81-1.31]

1.06

[0.69-1.56]

1.05

[0.85-1.27]

  1. *C44 ( Other malignant neoplasms of skin)